Browse Category

NYSE:ZTS 4 November 2025 - 26 December 2025

Zoetis Stock (ZTS) After Hours on Dec. 24, 2025: Price Action, Today’s Headlines, Analyst Forecasts, and What to Watch Before the Next Market Open

Zoetis Stock (ZTS) After Hours on Dec. 24, 2025: Price Action, Today’s Headlines, Analyst Forecasts, and What to Watch Before the Next Market Open

Zoetis shares closed up 1.6% at $125.50 in a shortened Christmas Eve session, then held steady in thin after-hours trading. About 2.36 million shares changed hands, with the day’s range between $123.06 and $125.68. The stock remains down roughly 24% over the past year. No major company news was released Dec. 24.
25 December 2025
Zoetis Stock (ZTS) News Today: $1.75B Convertible Notes, Accelerated Buybacks, Dividend Raise, and Analyst Forecasts (Dec. 17, 2025)

Zoetis Stock (ZTS) News Today: $1.75B Convertible Notes, Accelerated Buybacks, Dividend Raise, and Analyst Forecasts (Dec. 17, 2025)

Zoetis priced $1.75 billion in 0.25% convertible senior notes due 2029, with proceeds earmarked for share buybacks under its $6 billion repurchase program. Morgan Stanley cut its price target to $160 from $175, citing growth and competition concerns. Zoetis shares closed up 1.9% on Dec. 16 but remain far below early 2025 highs. The notes deal is set to close Dec. 18.
17 December 2025
Zoetis 2025: Animal Health Giant’s Latest Breakthroughs, Stock Outlook & Key Investor Insights

Zoetis 2025: Animal Health Giant’s Latest Breakthroughs, Stock Outlook & Key Investor Insights

Zoetis reported 2024 revenue of $9.3 billion, up 9% from 2023, with gross margins near 72% and net profit margin around 29%. Shares traded at $130–$135 in November 2025, down from a 52-week high of $180. The company raised its dividend by 15% to $2.00 per share. Analysts’ average 12-month target is $188, though some issued downgrades in late 2025 amid slowing growth.
Go toTop